talipexole has been researched along with Dyskinesia, Medication-Induced in 1 studies
talipexole: dopamine receptor agonist; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dosage of concurrent neuroleptics was fixed at least 3 weeks prior to the trial and was unchanged throughout the study period." | 1.29 | B-HT 920, a dopamine D2 agonist, in the treatment of negative symptoms of chronic schizophrenia. ( Inoue, T; Koyama, T; Matsubara, S; Ohmori, T; Yamashita, I, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohmori, T | 1 |
| Koyama, T | 1 |
| Inoue, T | 1 |
| Matsubara, S | 1 |
| Yamashita, I | 1 |
1 other study available for talipexole and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
B-HT 920, a dopamine D2 agonist, in the treatment of negative symptoms of chronic schizophrenia.
Topics: Arousal; Azepines; Brain; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induce | 1993 |